BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND SEPT6, RP5-876A24_2, 23157, ENSG00000125354, Q14141, SEP2, MGC16619, KIAA0128, MGC20339 AND Prognosis
9380 results:

  • 1. Predictive nomograms based on gamma-glutamyl transpeptidase to prealbumin ratio for prognosis of hepatocellular carcinoma patients without microvascular invasion.
    Ma M; Xie K; Jin T; Xu F
    BMC Cancer; 2024 May; 24(1):617. PubMed ID: 38773511
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The effect of liver metastases on clinical efficacy of first-line programmed death-1 inhibitor plus chemotherapy in esophageal squamous cell carcinoma: A post hoc analysis of ASTRUM-007 and meta-analysis.
    Gao J; Song Y; Kou X; Tan Z; Zhang S; Sun M; Zhou J; Fan M; Zhang M; Song Y; Li S; Yuan Y; Zhuang W; Zhang J; Zhang L; Jiang H; Gu K; Ye H; Ke Y; Qi X; Wang Q; Zhu J; Huang J
    Cancer Med; 2024 May; 13(10):e7203. PubMed ID: 38769930
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Effect of cytokines on advanced hepatocellular carcinoma prognosis receiving radiotherapy and tislelizumab plus anlotinib: a single-center phase II clinical trial.
    Lin YD; Wu GS; Rao MY; Liu YH; Han YW; Zhang J; Zhang JW
    Sci Rep; 2024 May; 14(1):11486. PubMed ID: 38769368
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A comprehensive analysis of the oncogenic and prognostic role of TBC1Ds in human hepatocellular carcinoma.
    Zhang P; Zhu L; Pan X
    PeerJ; 2024; 12():e17362. PubMed ID: 38766486
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Treatment and prognosis study of spontaneous rupture hemorrhage in hepatocellular carcinoma: Recommendations for adding the A1 stage to the BCLC staging system.
    Ni Q; Jia H; Zhang Y; Lu J; Chang H
    Cancer Med; 2024 May; 13(10):e6952. PubMed ID: 38752672
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Patterns of distant metastasis and survival outcomes in
    Liu K; Huang AL; Chen XQ; Wu SG
    Front Endocrinol (Lausanne); 2024; 15():1385756. PubMed ID: 38752173
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Construction of a prognostic model for extensive-stage small cell lung cancer patients undergoing immune therapy in northernmost China and prediction of treatment efficacy based on response status at different time points.
    Dang J; Xu G; Guo G; Zhang H; Shang L
    J Cancer Res Clin Oncol; 2024 May; 150(5):255. PubMed ID: 38750370
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. PSMD9 promotes the malignant progression of hepatocellular carcinoma by interacting with c-Cbl to activate EGFR signaling and recycling.
    Su Y; Meng L; Ge C; Liu Y; Zhang C; Yang Y; Tian W; Tian H
    J Exp Clin Cancer Res; 2024 May; 43(1):142. PubMed ID: 38745188
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Aprospective study of detection and clinical significance of bone marrow tumor cells in small cell lung cancer].
    Wang Y; Lu BH; Gao Y; Liu YX; Hu MM; Che NY; Lin HF; Li HX; Zhang HM; Zhang TM
    Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):419-427. PubMed ID: 38742355
    [No Abstract]    [Full Text] [Related]  

  • 10. Early detection and prognosis evaluation for hepatocellular carcinoma by circulating tumour DNA methylation: A multicentre cohort study.
    Guo DZ; Huang A; Wang YC; Zhou S; Wang H; Xing XL; Zhang SY; Cheng JW; Xie KH; Yang QC; Ma CC; Li Q; Chen Y; Su ZX; Fan J; Liu R; Liu XL; Zhou J; Yang XR
    Clin Transl Med; 2024 May; 14(5):e1652. PubMed ID: 38741204
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Development of a machine learning-based model to predict prognosis of alpha-fetoprotein-positive hepatocellular carcinoma.
    Dong B; Zhang H; Duan Y; Yao S; Chen Y; Zhang C
    J Transl Med; 2024 May; 22(1):455. PubMed ID: 38741163
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Transcript and protein signatures derived from shared molecular interactions across cancers are associated with mortality.
    Zhao Y; Li X; Loscalzo J; Smelik M; Sysoev O; Wang Y; Mahmud AKMF; Mansour Aly D; Benson M
    J Transl Med; 2024 May; 22(1):444. PubMed ID: 38734658
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Precise planning based on 3D-printed dry-laboratory models can reduce perioperative complications of laparoscopic surgery for complex hepatobiliary diseases: a preoperative cohort study.
    Yao WF; Huang XK; Fu TW; Jin L; Du CF; Gao ZY; Wang KD; Dai MG; Liu SY; Liu JW; Zhang CW; Liang L; Huang DS
    BMC Surg; 2024 May; 24(1):148. PubMed ID: 38734630
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. DGPRI, a new liver fibrosis assessment index, predicts recurrence of AFP-negative hepatocellular carcinoma after hepatic resection: a single-center retrospective study.
    Zhang B; Xue J; Xu B; Chang J; Li X; Huang Z; Zhao H; Cai J
    Sci Rep; 2024 May; 14(1):10726. PubMed ID: 38730095
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Multi-Omics profiling identifies aldehyde dehydrogenase 2 as a critical mediator in the crosstalk between Treg-mediated immunosuppression microenvironment and hepatocellular carcinoma.
    Liu ZY; Lin XH; Guo HY; Shi X; Zhang DY; Sun JL; Zhang GC; Xu RC; Wang F; Yu XN; Wang D; Weng SQ; Shen XZ; Liu TT; Dong L; Zhu JM
    Int J Biol Sci; 2024; 20(7):2763-2778. PubMed ID: 38725845
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. RRP8, associated with immune infiltration, is a prospective therapeutic target in hepatocellular carcinoma.
    You K; Du X; Zhao Y; Wen F; Lu Z; Fan H
    J Cancer Res Clin Oncol; 2024 May; 150(5):245. PubMed ID: 38722372
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. IL-2RG as a possible immunotherapeutic target in CRC predicting poor prognosis and regulated by miR-7-5p and miR-26b-5p.
    Gharib E; Rejali L; Piroozkhah M; Zonoobi E; Nasrabadi PN; Arabsorkhi Z; Baghdar K; Shams E; Sadeghi A; Kuppen PJK; Salehi Z; Nazemalhosseini-Mojarad E
    J Transl Med; 2024 May; 22(1):439. PubMed ID: 38720389
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Diacylglycerol kinase alpha is a proliferation marker of intrahepatic cholangiocarcinoma associated with the prognosis.
    Shichi S; Sugiyama K; Asahi Y; Shirakawa C; Nakamoto H; Kimura S; Wakizaka K; Aiyama T; Nagatsu A; Orimo T; Kakisaka T; Taketomi A
    Cancer Med; 2024 May; 13(9):e7238. PubMed ID: 38716625
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Analysis of factors affecting the prognosis of patients with pancreatic cancer patients with obstructive jaundice].
    Zhang L; Li M; Sun QF; Yu HP
    Zhonghua Nei Ke Za Zhi; 2024 May; 63(5):474-479. PubMed ID: 38715484
    [No Abstract]    [Full Text] [Related]  

  • 20. Comprehensive Analysis of the Immunosuppressive Function of Regulatory T Cells in Human Hepatocellular Carcinoma Tissues.
    Ge J; Chen J; Shen Q; Zheng X; Chen X; Shi L; Chen L; Xu B
    Cancer Control; 2024; 31():10732748241251580. PubMed ID: 38712609
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 469.